Jack In The Box Partnership Helps Weedmaps Report Positive Q1 Earnings Despite Revenue Decrease

WM Technology (NASDAQ: MAPS), a leading technology and software infrastructure provider to the cannabis industry, announced

WM Technology (NASDAQ:MAPS), a leading technology and software infrastructure provider to the cannabis industry, announced its financial results for Q1 2023 on May 9.

Despite a decrease in revenue compared to the prior year period, Weedmaps reported positive adjusted EBITDA and a significantly reduced net loss, attributing the results to strategic actions taken to improve its bottom line.

Weedmaps Boosts Bottom Line

  • The company reported revenue of $48 million in the first quarter ending March 31, 2023, compared to $57.5 million in the first quarter of 2022.
  • WM Technology had a net loss of $4 million, compared to a net loss of $31.2 million in the prior year period. However, adjusted EBITDA was positive at $7.1 million compared to $(1.0) million in the prior year period.
  • The firm attributed the positive results to strategic actions taken since November to improve its bottom line and its focus on marketplace experience and delivering value to clients.
  • In addition, the firm reported record numbers of orders placed on the platform during the 420 holidays in April 2023. The company executed over 30 in-market activations across 12 states, offering deals and driving awareness of the Weedmaps platform.

Weedmaps’ Partnership With Jack In The Box Drives Sales

  • The company also experienced record numbers of orders during the 420 holidays in April 2023 and launched an innovative partnership with Jack in the Box Inc. to promote its Pineapple Express Shake.
  • Looking ahead, WM Technology issued guidance for the second quarter of 2023, estimating revenue to be consistent with the first quarter of 2023, and non-GAAP adjusted EBITDA to be approximately $4 million.

Price Action 

MAPS shares were trading higher by 3.03% at $0.79 per share, after market close. 

Photo Credits: Tumisu on Pixabay.

Total
0
Shares
Related Posts
Read More

Aurora Touts 41% YoY Increase In International Medical Cannabis Q3 Revenue, Expands In Australia Via New Acquisition

Canadian medical cannabis company Aurora Cannabis reported its financial and operational results for Q3 2024. Net revenue increased to CAD64.4m ($42m), up from CAD61.1m in the same quarter the previous year. Medical cannabis net revenue rose by 16% to CAD45.1m, representing 70% of Aurora's consolidated net revenue. Gross profit reached CAD19.8m, up from CAD3.7m in Q3 2022, with adjusted gross profit before fair value adjustments increasing to CAD32.4m from CAD28m. The company recorded a CAD25.5m net loss compared to CAD67.2m in the same quarter in the previous year. Adjusted EBITDA came in at CAD4.3m, up from CAD3m. Miguel Martin, CEO of Aurora, said the company's international medical net revenue had seen year-on-year growth of 41%.

ACB